Today: 25 January 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

BigBear.ai (BBAI) Stock Jumps on Defense‑AI Hype: Latest Price, Forecast and Dilution Risks as of December 4, 2025

BigBear.ai (BBAI) Stock Jumps on Defense‑AI Hype: Latest Price, Forecast and Dilution Risks as of December 4, 2025

BigBear.ai Holdings, Inc. (NYSE: BBAI) is back in the spotlight. The defense‑focused artificial intelligence stock is trading near multi‑month highs after a sharp rebound driven by its Ask Sage acquisition, new international deals, and a wave of interest in “mission‑ready” AI for national security. At the same time, investors are wrestling with falling revenue, heavy losses, and a plan to…
4 December 2025
····
USA Rare Earth (USAR) Stock on December 4, 2025: New Supply Deal, Stillwater Magnet Plant, and Russell 2000 Inclusion – Is the Mine‑to‑Magnet Bet Worth It?

USA Rare Earth (USAR) Stock on December 4, 2025: New Supply Deal, Stillwater Magnet Plant, and Russell 2000 Inclusion – Is the Mine‑to‑Magnet Bet Worth It?

Snapshot: Where USA Rare Earth Stock Stands Today USA Rare Earth, Inc. (NASDAQ: USAR) has turned into one of the noisiest small caps in the critical minerals space in 2025 – part national‑security story, part SPAC saga, part good old‑fashioned speculative growth stock. As of mid‑day on December 4, 2025, USAR is trading in the mid‑$16s, up roughly 18% on…
4 December 2025
··
Aurora Innovation (AUR) Stock Surges on Insider Buying and Driverless Milestones: Latest Price, News and 2026 Forecast (4 December 2025)

Aurora Innovation (AUR) Stock Surges on Insider Buying and Driverless Milestones: Latest Price, News and 2026 Forecast (4 December 2025)

Updated: December 4, 2025 Key takeaways AUR stock today: rally continues into December 4, 2025 As of mid‑day trading on December 4, 2025, Aurora Innovation, Inc. (NASDAQ: AUR) is changing hands around $4.64 per share, up roughly 2–3% on the session. Investing Over the last two weeks, the stock has staged a notable rebound. Technical analysts at StockInvest calculate that…
4 December 2025
····
IonQ, Inc. (IONQ) Stock Jumps on Quantum-AI and Defense Deals: December 4, 2025 Outlook

IonQ, Inc. (IONQ) Stock Jumps on Quantum-AI and Defense Deals: December 4, 2025 Outlook

IonQ’s stock is having another very “on‑brand” quantum day: volatile, loud, and hard to ignore. Around midday on December 4, 2025, IonQ, Inc. (NYSE: IONQ) was trading in the mid‑$50s, up double digits intraday after a string of headlines tying the company to biotech, defense drones, and big institutional money. StockAnalysis shows the shares around $54.20, up about 11%, in…
4 December 2025
····
Oklo Stock Soars 13% as Nuclear Policy Tailwinds Return: Latest OKLO News, Forecasts and Analysis (December 4, 2025)

Oklo Stock Soars 13% as Nuclear Policy Tailwinds Return: Latest OKLO News, Forecasts and Analysis (December 4, 2025)

Oklo Inc. (NYSE: OKLO) is back in the spotlight. On December 4, 2025, the fast‑reactor startup’s stock jumped roughly 13% to about $109.62 per share, bouncing from a bruising correction and reigniting the debate over whether OKLO is a generational nuclear opportunity or a textbook speculative bubble. FX Leaders This article pulls together the latest news, analyst forecasts, and expert…
4 December 2025
···
Aequs IPO Day 2 Subscription Soars 11.1x; GMP Around ₹45–46 Signals Up to 37% Listing Gains

Aequs IPO Day 2 Subscription Soars 11.1x; GMP Around ₹45–46 Signals Up to 37% Listing Gains

New Delhi | December 4, 2025 The ₹921.81 crore initial public offering (IPO) of precision manufacturing company Aequs Limited is seeing powerful demand on its second day of bidding, with the issue subscribed about 11.10 times by the close of trade on Thursday, December 4, according to exchange-based data compiled by multiple platforms. Groww Strong interest from retail investors and…
4 December 2025
····
AST SpaceMobile (ASTS) Soars as BlueBird 6 Launch Nears: Latest News, Stock Forecasts and Analysis as of 4 December 2025

AST SpaceMobile (ASTS) Soars as BlueBird 6 Launch Nears: Latest News, Stock Forecasts and Analysis as of 4 December 2025

AST SpaceMobile, Inc. (NASDAQ: ASTS) is back in the spotlight. The satellite‑to‑smartphone pioneer’s share price has jumped into the low‑$70s, powered by a wave of manufacturing expansion news, a firm launch date for its next‑generation BlueBird 6 satellite, and a string of big‑name carrier deals across the U.S., Europe and the Middle East. Business Wire Below is a detailed rundown…
4 December 2025
····
Adani Group to Invest ₹1.35 Lakh Crore in Airport Expansion, Target 200 Million Passengers by 2030

Adani Group to Invest ₹1.35 Lakh Crore in Airport Expansion, Target 200 Million Passengers by 2030

MUMBAI/NEW DELHI, December 4, 2025 — The Adani Group is preparing one of the largest private bets on India’s aviation infrastructure, planning to invest about ₹1.35 lakh crore (roughly US$15 billion) over the next five years to boost annual passenger capacity at its airports to 200 million by 2030. India Brand Equity Foundation The expansion plan, first reported by Bloomberg…
4 December 2025
··
Netflix Stock Today: Warner Bros. Bid Jitters Drag NFLX Lower as Wall Street Still Sees Big Upside

Netflix Stock Today: Warner Bros. Bid Jitters Drag NFLX Lower as Wall Street Still Sees Big Upside

Netflix (NASDAQ: NFLX) is having a volatile week again. By midday on Thursday, December 4, the stock was trading around $102 per share, down almost 2% on the session and extending Wednesday’s near‑5% drop. StockAnalysis After a strong run earlier this year, Netflix is now roughly 22% below its late‑June all‑time high near $134, and hovering in the lower half…
4 December 2025
····
EQT Corporation (EQT) Stock Hits Record High as Analysts Lift Targets – Latest News, Forecasts and 2026–2027 Outlook

EQT Corporation (EQT) Stock Hits Record High as Analysts Lift Targets – Latest News, Forecasts and 2026–2027 Outlook

PITTSBURGH — December 4, 2025 — EQT Corporation (NYSE: EQT), the largest U.S. natural gas producer, is trading near record territory after a powerful multi‑month rally driven by stronger margins, a vertically integrated gas platform and renewed optimism around LNG and AI‑driven power demand. Yahoo Finance As of late‑morning U.S. trading on Thursday, EQT stock was changing hands around $60…
4 December 2025
····
Accenture (ACN) Stock on December 4, 2025: AI Restructuring, OpenAI Deal and 2026 Forecasts Explained

Accenture (ACN) Stock on December 4, 2025: AI Restructuring, OpenAI Deal and 2026 Forecasts Explained

New York, December 4, 2025 — Accenture plc (NYSE: ACN) is deep into a self‑described “reinvention” built around artificial intelligence at the same time its stock is still well below last year’s peak. On Thursday, Accenture shares were trading around $271.47, giving the company a market capitalization of roughly $168.5 billion, with a trailing P/E ratio of about 22.3 and…
4 December 2025
····
Humana Stock (HUM) Outlook December 4, 2025: Earnings Beat, Legal Risks and 2026 Medicare Advantage Forecast

Humana Stock (HUM) Outlook December 4, 2025: Earnings Beat, Legal Risks and 2026 Medicare Advantage Forecast

Date: December 4, 2025Ticker: Humana Inc. (NYSE: HUM) Humana’s share price spent most of 2025 behaving like a stressed-out cardiogram: sharp drops around guidance cuts and star-rating headlines, then sharp rebounds when the numbers looked less bad than feared. As of early trading on December 4, Humana stock is changing hands in the mid‑$250s, down roughly 12% over the past…
4 December 2025
··
1 … 636 637 638 639 640 … 720

Stock Market Today

  • Novo Nordisk Shares Seen as Undervalued Despite 27.8% Drop Over Past Year
    January 25, 2026, 10:48 AM EST. Novo Nordisk's (NYSE:NVO) stock has declined 27.8% over the past year but gained 18.8% in the last month. Despite this, a discounted cash flow (DCF) model estimates an intrinsic value of $149.81 per share, suggesting shares trade at a 58.4% discount to fair value. Novo Nordisk scored 5 out of 6 on Simply Wall St's valuation framework, indicating undervaluation on most metrics. Analysts forecast free cash flow growth through 2030, supporting bullish long-term prospects. The recent mixed return profile and ongoing interest as a leading pharma firm frame current investor debates on valuation and risks. Novo Nordisk remains a key biotech name under close watch for potential upside against recent price weakness.
Go toTop